This paper is in the following e-collection/theme issue:

Teledermatology (61) Surveillance Systems (466)

Published on in Vol 5, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40623, first published .
Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study

Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study

Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study

Authors of this article:

Dorothy Drabarek1 Author Orcid Image ;   Emily Habgood2 Author Orcid Image ;   Deonna Ackermann1 Author Orcid Image ;   Jolyn Hersch1 Author Orcid Image ;   Monika Janda3 Author Orcid Image ;   Rachael L Morton4 Author Orcid Image ;   Pascale Guitera5, 6, 7 Author Orcid Image ;   H Peter Soyer8, 9 Author Orcid Image ;   Helena Collgros6, 7 Author Orcid Image ;   Anne E Cust1, 5, 10 Author Orcid Image ;   Robyn PM Saw5, 7, 11 Author Orcid Image ;   Jon Emery2 Author Orcid Image ;   Victoria Mar12 Author Orcid Image ;   Mbathio Dieng4 Author Orcid Image ;   Anthony Azzi13, 14 Author Orcid Image ;   Alister Lilleyman13 Author Orcid Image ;   Katy JL Bell1 Author Orcid Image
Article Authors Cited by (2) Tweetations (10) Metrics

Journals

  1. Drabarek D, Ackermann D, Medcalf E, Bell K. Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial. JMIR Dermatology 2023;6:e45865 View
  2. Ackermann D, Hersch J, Janda M, Bracken K, Turner R, Bell K. Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma. Contemporary Clinical Trials 2024;140:107513 View